1. New Insights into Mechanisms of Long-term Protective Anti-tumor Immunity Induced by Cancer Vaccines Modified by Virus Infection
   Volker Schirrmacher, 2020, Biomedicines CrossRef
2. Fifty Years of Clinical Application of Newcastle Disease Virus: Time to Celebrate!
   Volker Schirrmacher, 2016, Biomedicines CrossRef
3. Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity
   Robin J. Prestwich et al, 2008, Clinical Cancer Research CrossRef
4. Fusogenic Viruses in Oncolytic Immunotherapy
   Teresa Krabbe et al, 2018, Cancers CrossRef
5. Immunogenic Apoptosis as a Novel Tool for Anticancer Vaccine Development
   Barbara Montico et al, 2018, International Journal of Molecular Sciences CrossRef
6. Multimodal Cancer Therapy Involving Oncolytic Newcastle Disease Virus, Autologous Immune Cells, and Bi-Specific Antibodies
   Volker Schirrmacher et al, 2014, Frontiers in Oncology CrossRef
7. Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus
   Volker Schirrmacher, 2022, Biomedicines CrossRef
8. Cancer Vaccines and Oncolytic Viruses Exert Profoundly Lower Side Effects in Cancer Patients than Other Systemic Therapies: A Comparative Analysis
   Volker Schirrmacher, 2020, Biomedicines CrossRef
9. Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
   Lien Vandenberk et al, 2016, Frontiers in Immunology CrossRef
10. Unraveling the Effects of a Talimogene Laherparepvec (T-VEC)-Induced Tumor Oncolysate on Myeloid Dendritic Cells
    Jens Tijtgat et al, 2021, Frontiers in Immunology CrossRef